Loading…
Immunai provides an immune-focused drug discovery and development platform for biopharmaceutical companies and research institutions. The company uses multiomic data, machine learning, and functional genomics to assist in target discovery, preclinical evaluation, and clinical trial optimization.
AI named Immunai in June 2026.